Ocimum Biosolutions is a leading integrated genomics company providing comprehensive Genomic Reference Databases, Life-Science Lab Information Management Solutions, GLP compliant Microarray Services and essential research consumables. Majority of the leading Pharma companies, leading research institutes and emerging biotech companies worldwide choose Ocimum as their preferred outsourcing partner and utilize Ocimum's expertise for understanding underlying mechanisms of diseases, discovery and prioritization of gene targets & biomarkers.

In creating the world's largest commercial gene expression databases – BioExpress® and ToxExpress®, we have developed expertise and capabilities that are unparalleled in the genomic services industry. Our Specialty LIMS solution- Biotracker™ caters to the growing needs of core labs in global Companies and Research Centers involved in Life-Science Research. We provide multiple GLP-compliant platforms for gene expression and SNP genotyping data generation. We also provide full biorepository and genomic services support for the Genetic Alliance, which is an umbrella organization representing ~600 genetic advocacy groups. Besides providing the physical infrastructure for storing thousands of biological samples, we provide services to assist sample accrual, IRB approvals, CRO training, sample collection, clinical data capture and management.

Ocimum is backed by blue-chip investors (IFC, Kubera Partners LLC), reputed Board members with domain expertise and has a strong corporate governance.

Ocimum acquired the MWG Microarray assets in 2005, an European based Oligo manufacturing company, Isogen Biosolutions B.V. in 2006 and bought Gene Logic's genomics division in 2007.

Ocimum is a winner of IT Innovation award by NASSCOM in 2005, winner of Red Herring Asia 100 award 2006, Deloitte Top 50 India and Top 500 Asia-Pacific Award from 2005-2008. Ocimum was among the Top 10 in the Deloitte Top 50 India Awards in 2008.